Figure 1.
The survival advantage of SHDT patients over CT patients. Survival from diagnosis (A; n = 88), from time of study entry (B; n = 88), and from time of symptomatic disease (C; n = 66) of all patients treated with SHDT (- - -) and CT (—).
The survival advantage of SHDT patients over CT patients. Survival from diagnosis (A; n = 88), from time of study entry (B; n = 88), and from time of symptomatic disease (C; n = 66) of all patients treated with SHDT (- - -) and CT (—).
